Skip to main content

Table 4 Distribution of AKI incidence by baseline eGFR and AKI stage

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

 

eGFR (ml/min/1.732)

AKI Stage

<30

30-60

>60

 

n

Person time (years)

Incidence rate (per 1000 person-years)

n

Person time (years)

Incidence rate (per 1000 person-years)

n

Person time (years)

Incidence rate (per 1000 person-years)

1

439

1829

240

2187

31,350

70

1717

84,163

20

2

16

1829

8.7

43

31,350

1.3

81

84,163

1.0

3

167

1829

91

142

31,350

4.5

129

84,163

1.5